Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Conmed (CNMD) Treasury Shares (2016 - 2025)

Conmed's Treasury Shares history spans 16 years, with the latest figure at $12.9 million for Q4 2025.

  • For Q4 2025, Treasury Shares fell 17.53% year-over-year to $12.9 million; the TTM value through Dec 2025 reached $12.9 million, down 17.53%, while the annual FY2025 figure was $12.9 million, 17.53% down from the prior year.
  • Treasury Shares reached $153000.0 in Q4 2025 per CNMD's latest filing, down from $344143.0 in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $2.2 million in Q1 2021 to a low of $153000.0 in Q4 2025.
  • Average Treasury Shares over 5 years is $900697.2, with a median of $558850.5 recorded in 2023.
  • Peak YoY movement for Treasury Shares: crashed 60.86% in 2022, then increased 18.02% in 2024.
  • A 5-year view of Treasury Shares shows it stood at $54.1 million in 2021, then tumbled by 57.86% to $22.8 million in 2022, then crashed by 34.2% to $15.0 million in 2023, then grew by 4.27% to $15.6 million in 2024, then fell by 17.53% to $12.9 million in 2025.
  • Per Business Quant, the three most recent readings for CNMD's Treasury Shares are $12.9 million (Q4 2025), $13.5 million (Q3 2025), and $13.9 million (Q2 2025).